CCM
BSX icon

Conway Capital Management’s Boston Scientific BSX Stock Holding History

Conway Capital Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.81M Sell
28,900
-495
-2% -$39.6K 0.85% 18
2025
Q4 		$2.8M Sell
29,395
-250
-0.8% -$24.5K 1.19% 14
2025
Q3 		$2.89M Hold
29,645
– – 1.21% 15
2025
Q2 		$3.18M Sell
29,645
-1,725
-5% -$175K 1.42% 15
2025
Q1 		$3.16M Sell
31,370
-555
-2% -$55.9K 1.58% 15
2024
Q4 		$2.85M Hold
31,925
– – 1.26% 16
2024
Q3 		$2.68M Hold
31,925
– – 1.3% 17
2024
Q2 		$2.46M Hold
31,925
– – 1.24% 15
2024
Q1 		$2.19M Hold
31,925
– – 1.22% 15
2023
Q4 		$1.85M Sell
31,925
-2,090
-6% -$112K 1.19% 16
2023
Q3 		$1.8M Sell
34,015
-3,375
-9% -$177K 1.31% 15
2023
Q2 		$2.02M Sell
37,390
-2,550
-6% -$133K 1.42% 14
2023
Q1 		$2M Sell
39,940
-2,650
-6% -$125K 1.64% 14
2022
Q4 		$1.97M Buy
42,590
+7,250
+21% +$314K 1.99% 13
2022
Q3 		$1.37M Sell
35,340
-135
-0.4% -$5.42K 1.22% 17
2022
Q2 		$1.32M Sell
35,475
-550
-2% -$22.4K 1.18% 19
2022
Q1 		$1.6M Buy
36,025
+4,875
+16% +$211K 1.02% 18
2021
Q4 		$1.32M Buy
31,150
+2,000
+7% +$84K 0.78% 23
2021
Q3 		$1.26M Hold
29,150
– – 0.86% 24
2021
Q2 		$1.25M Hold
29,150
– – 0.85% 24
2021
Q1 		$1.13M Sell
29,150
-1,800
-6% -$68.1K 0.84% 25
2020
Q4 		$1.11M Buy
+30,950
New +$1.12M 0.81% 25

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Conway Capital Management's BSX Position: Q1 2026 in Review

Conway Capital Management reduced its Boston Scientific (BSX) stake by 1.7% in Q1 2026, selling an estimated $39.6K and leaving 28,900 shares worth $1.81M. The position accounts for 0.85% of the portfolio, ranked #18.

Conway Capital Management first reported a position in BSX in Q4 2020 and has held it in 22 quarters since. The position peaked at $3.18M in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Conway Capital Management held 28,900 shares of Boston Scientific worth $1.81M as of Q1 2026.
  • Conway Capital Management sold 495 Boston Scientific shares in Q1 2026, an estimated $39.6K.
  • Boston Scientific made up 0.85% of Conway Capital Management's portfolio in Q1 2026, its #18 holding.
  • Conway Capital Management first reported a position in Boston Scientific in Q4 2020 and has held it in 22 quarters since.
  • Conway Capital Management's Boston Scientific position peaked at $3.18M in Q2 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Conway Capital Management's 13F filing for Q1 2026, filed 7 May 2026.